Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex

By M. Cnop, P. Havel, K. Utzschneider, Daniel B. Carr, M. Sinha, E. Boyko, B. Retzlaff, R. Knopp, J. Brunzell, S. Kahn. Diabetologia, 2003

1,552 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Physiology

View Paper: https://www.semanticscholar.org/paper/6199f58bebe7bcde75e4b76cac54e6394552960f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. B. Vergès
2. Hannele Yki-Järvinen
3. Marja-Riitta Taskinen
4. H. Fang
5. R. L. Judd

In Epidemiology

1. Hannele Yki-Järvinen
2. I. Azevedo
3. R. Monteiro
4. H. Fang
5. R. L. Judd
6. S. Fried
7. A. Gressner

In Physiology

1. G. De Pergola
2. Hannele Yki-Järvinen
3. Marja-Riitta Taskinen
4. I. Azevedo
5. R. Monteiro
6. H. Fang
7. R. L. Judd
8. C. Mantzoros

Citations in the corpus

• Obesity and cancer risk: Emerging biological mechanisms and perspectives. (2019, background): “excessive ectopic fat distribution are strongly associated with hypoadiponectinemia [102].”
• Effects of eight weeks of time-restricted feeding (16/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistance-trained males (2016, background): “The concurrent increase in adiponectin and decrease in insulin may be related to modulation of insulin sensitivity, as adiponectin concentrations have been positively correlated with insulin sensitivity [21, 50, 63, 64].”
• Pathophysiology of diabetic dyslipidaemia: where are we? (2015, background): “In non-diabetic individuals, as in patients with type 2 diabetes, plasma adiponectin is negatively correlated with plasma triacylglycerols and positively correlated with plasma HDLcholesterol, and these associations are independent of insulin resistance [16, 112].”
• Obesity as a Major Risk Factor for Cancer (2013, background): “However, adiponectin serum levels correlate negatively with BMI and even more negatively with visceral adiposity [78] while insulin and estrogens may suppress its secretion [79].”
• Chronic Inflammation in Obesity and the Metabolic Syndrome (2010, background): “On the other hand, it is a feabler producer of adiponectin, an adipokine more strongly correlated with subcutaneous fat [68].”
• Adiponectin Regulation and Function (2018, positive): “However, adipose mass itself also plays a role in plasma adiponectin concentrations, with visceral adipose tissue mass negatively associated with plasma adiponectin concentrations (41, 81).”